Brief: AB Science To Present Results From Masitinib Study Ab07015 At American Thoracic Society Symposium
13/10/2020 17:26
Oct 13 (Reuters) - AB SCIENCE SA ABS.PA :
* ANNOUNCES THAT RESULTS FROM MASITINIB STUDY AB07015 IN
SEVERE
ASTHMA HAVE BEEN SELECTED FOR PRESENTATION AT AN ATS SYMPOSIUM
HELD ON 16TH OCTOBER, 2020
Source text for Eikon: ID:nGNE5495gH
Further company coverage: ABS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on AB Science SA
See all newsBrief: AB Science Expects To Resume AB8939 Phase 1 In Q1 2027 And Masitinib Phase 3 In Q4 2027
Brief: AB Science Discontinues Phase 2 AB20006, Phase 3 AB15003, Phase 3 AB20009 Studies
Brief: AB Science Temporarily Halts Europe Clinical Trials Ahead Of Strategic Reorganization
Brief: AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet
Brief: AB Science Says Co Received Japanese Patent Protection To Use Masitinib In Progressive MS Until 2041